Alpha-antitrypsin topical - Arriva-ProMetic

Drug Profile

Alpha-antitrypsin topical - Arriva-ProMetic

Alternative Names: AAT topical - Arriva-ProMetic; Alpha-1 antitrypsin - Arriva-ProMetic; AP-102 gel; Dermolastin; rAAT gel; rAAT topical - Arriva-ProMetic

Latest Information Update: 31 Oct 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Arriva-ProMetic
  • Class Acute-phase proteins; Alpha globulins; Blood proteins; Secretory proteinase inhibitory proteins; Serpins
  • Mechanism of Action Serine endopeptidase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Atopic dermatitis; Dermatitis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 31 Oct 2006 No development reported - Phase-II for Atopic dermatitis in Canada (Topical)
  • 31 Oct 2006 No development reported - Phase-II for Dermatitis in United Kingdom (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top